[Federal Register Volume 83, Number 38 (Monday, February 26, 2018)]
[Notices]
[Pages 8287-8288]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03853]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Request for Nominations

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Request for Nominations to the Centers for Disease Control and 
Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment.

-----------------------------------------------------------------------

SUMMARY: HRSA is seeking nominations of four qualified candidates to be 
considered for appointment as members of the CDC/HRSA Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment 
(Committee). The Committee consists of 18 public

[[Page 8288]]

members, including two co-chairs. The Committee membership maintains a 
balance of diverse experiences and expertise. Those requesting 
consideration require expertise in areas such as: Public health; 
epidemiology; laboratory practice; immunology; infectious diseases; 
behavioral health and science including, but not limited to opioid use 
and related expertise; health education; healthcare delivery; state 
health programs; clinical care; preventive health; medical education; 
health services and clinical research; and healthcare financing. In 
addition, people living with HIV and affected populations as well as 
individuals employed by state and local health and education agencies, 
HIV/viral hepatitis/STD community-based organizations, and the ethics 
or religious community are encouraged to submit nomination packages for 
consideration. Current federal employees will not be considered.

DATES: Written nominations for membership to the Committee must be 
received on or before May 30, 2018. Packages received after this time 
will not be considered for the current membership cycle. (See 
SUPPLEMENTARY INFORMATION, below, for required documentation.)

ADDRESSES: Submit your electronic nomination package by electronic mail 
to [email protected].

FOR FURTHER INFORMATION CONTACT: CDR Holly Berilla, HRSA, HIV/AIDS 
Bureau by email at [email protected] or by telephone at (301) 
443-9965. A copy of the Committee Charter and background information 
can be obtained by accessing the Advisory Committee website at https://www.cdc.gov/maso/facm/facmchachspt.html.

SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment was established under 
Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 
217a], as amended.
    The purpose of the Committee is to advise the Secretary, HHS; the 
Director, CDC; and the Administrator, HRSA regarding objectives, 
strategies, policies, and priorities for HIV, viral hepatitis, and 
other STD prevention and treatment efforts including surveillance of 
HIV infection, AIDS, viral hepatitis, and other STDs, and related 
behaviors; epidemiologic, behavioral, health services, and laboratory 
research on HIV, viral hepatitis, and other STDs; identification of 
policy issues related to HIV/viral hepatitis/STD professional 
education, patient healthcare delivery, and prevention services; Agency 
policies about prevention of HIV, viral hepatitis and other STDs, 
treatment, healthcare delivery, and research and training; strategic 
issues influencing the ability of CDC and HRSA to fulfill their 
missions of providing prevention and treatment services; programmatic 
efforts to prevent and treat HIV, viral hepatitis, and other STDs; and 
support to the Agencies in their developoment of responses to emerging 
health needs related to HIV, viral hepatitis, and other STDs.
    Members selected will be considered special government employees 
(SGEs) and may be invited to serve four (4) year terms. SGEs are 
eligible to receive a stipend and reimbursement for per diem and any 
travel expenses incurred for attending Committee meetings, as 
authorized by section 5 U.S.C. 5703 for persons employed intermittently 
in government service. Approved nominees will be invited to serve 
during calendar year 2019.
    The following information must be included in the electronic 
nomination package for each individual to be considered for nomination: 
(1) A statement clearly indicating the name and affiliation of the 
nominee, the basis for the nomination (i.e., specific attributes such 
as experience, education, current affiliations, positions, etc.), and 
that the nominee is willing to serve as a member of the Committee; (2) 
the nominee's name, address, and daytime telephone number and the home/
or work address, and email address; and (3) a current copy of the 
nominee's curriculum vitae. Nomination packages may be summited 
directly by the individual being nominated or by the person/
organization recommending the candidate.
    HHS is required to ensure that the membership of the Committee is 
balanced in terms of points of view represented. Every effort is made 
to ensure that individuals from a broad representation of geographic 
areas, gender, ethnic and minority groups, as well as individuals with 
disabilities are given consideration for membership and therefore, HHS 
encourages nominations of qualified candidates from these groups. HHS 
also encourages geographic diversity in the composition of the 
Committee. Appointments shall be made without discrimination based on 
age, ethnicity, gender, sexual orientation, and cultural, religious, or 
socioeconomic status.
    Individuals who are selected for appointment will be required to 
provide detailed information regarding their financial holdings, 
consultancies, and research grants or contracts. Disclosure of this 
information is necessary in order to determine if the selected 
candidate is involved in any activity that may pose a potential 
conflict with the official duties to be performed as a member of the 
Committee.

Amy McNulty,
Acting Director, HRSA, Division of the Executive Secretariat.
[FR Doc. 2018-03853 Filed 2-23-18; 8:45 am]
 BILLING CODE 4165-15-P